US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALGERNON HEALTH INC.

0.0285

-0.0070-19.72%

Volume:23.02K

Turnover:701.36

Market Cap:1.35M

PE:-0.65

High:0.0330

Open:0.0330

Low:0.0285

Close:0.0355

52wk High:0.0719

52wk Low:0.0285

Shares:47.33M

Float Shares:34.26M

Volume Ratio:2.32

T/O Rate:0.07%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0440

ROE:-90.47%

ROA:-26.16%

PB:1.26

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

ALGERNON HEALTH INC.

Exchange:

OTCQB

Establishment Date:

2015

Employees:

- -

Office Location:

601 West Broadway,Suite 400,Vancouver,British Columbia,Canada

Website:

https://algernonpharmaceuticals.com/

Zip Code:

V5Z 4C2

Phone:

Fax:

- -

Introduction:

Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of nonalcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada, Australia, and New Zealand. The company's pipeline includes Ifenprodil, which completed Phase 2 clinical trial for the treatment of idiopathic pulmonary fibrosis and chronic cough; repirinast, which is in preclinical stage for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine, which has completed preclinical stage for the treatment of strokes. The company was formerly known as Breathtec Biomedical, Inc. and changed its name to Algernon Pharmaceuticals Inc. in July 2015. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AGNPF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AGNPF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGNPF\",,,,,undefined,":{"symbol":"AGNPF","market":"US","secType":"STK","nameCN":"ALGERNON HEALTH INC.","latestPrice":0.0285,"timestamp":1771621200000,"preClose":0.0355,"halted":0,"volume":23024,"delay":15,"changeRate":-0.1971830985915492,"floatShares":34256200,"shares":47332431,"eps":-0.044,"marketStatus":"Market Closed","change":-0.007,"latestTime":"02-20 16:00:00 EST Delay","open":0.033,"high":0.033,"low":0.0285,"amount":701.361,"amplitude":0.126761,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.044,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"exchange":"OTCQB","adjPreClose":0.0355,"volumeRatio":2.3200322310356776},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGNPF\",,,,,undefined,":{"symbol":"AGNPF","floatShares":34256200,"roa":"-26.16%","roe":"-90.47%","lyrEps":0,"volumeRatio":2.3200322310356776,"shares":47332431,"dividePrice":0,"high":0.033,"amplitude":0.126761,"preClose":0.0355,"low":0.0285,"week52Low":0.0285,"pbRate":"1.26","week52High":0.0719,"institutionHeld":0,"latestPrice":0.0285,"eps":-0.044,"divideRate":0,"volume":23024,"delay":15,"ttmEps":-0.044,"open":0.033,"prevYearClose":0.05,"prevWeekClose":0.0384,"prevMonthClose":0.0396,"prevQuarterClose":0.05,"fiveDayClose":0.0384,"twentyDayClose":0.0395,"sixtyDayClose":0.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGNPF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-12-23","symbol":"AGNPF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1734930000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-07-29","symbol":"AGNPF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722225600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-12-29","symbol":"AGNPF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1703826000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-03-03","symbol":"AGNPF","defaultRemindTime":1677853800000,"type":"split","dateTimestamp":1677819600000,"forFactor":1,"toFactor":4,"ratio":0.25},{"market":"US","date":"2021-11-24","symbol":"AGNPF","defaultRemindTime":1637764200000,"type":"split","dateTimestamp":1637730000000,"forFactor":100,"toFactor":1,"ratio":100}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGNPF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGNPF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":327047624,"yearFounded":2015,"address":"601 West Broadway,Suite 400,Vancouver,British Columbia,Canada","zipCode":"V5Z 4C2","officePhone":"604 398 4175"},"stockCompanyDetail":{"websiteUrl":"https://algernonpharmaceuticals.com/","description":"Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of nonalcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada, Australia, and New Zealand. The company's pipeline includes Ifenprodil, which completed Phase 2 clinical trial for the treatment of idiopathic pulmonary fibrosis and chronic cough; repirinast, which is in preclinical stage for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine, which has completed preclinical stage for the treatment of strokes. The company was formerly known as Breathtec Biomedical, Inc. and changed its name to Algernon Pharmaceuticals Inc. in July 2015. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.","exchange":"OTCQB","name":"ALGERNON HEALTH INC.","nameEN":"ALGERNON HEALTH INC."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AGNPF\",market:\"US\",,,undefined,":null}}